Title– Metabolism of 5-fluorooxindole by Human Liver Cytochrome P450 Enzymes
Program of Study– Biomedical Sciences
Presentation Type– Physical Poster
Subtype– Basic
Mentor and Mentor Email– Dr. Gregory Raner (graner@liberty.edu)
Student Name and Email– Julianna Campbell (jcampbell46@liberty.edu)
Abstract: The compound that is being explored as part of this research project is 5fluorooxindole (5F2O) and is a common chemical compound found in several recently
developed drugs, including the anti-cancer drug Famitinib. It is a derivative of the amino acid
tryptophan, and its structure is useful for drug targeting due to its ability to donate and accept
hydrogen bonds. While metabolism of fluorooxindole-containing products can involve a variety
of chemical reactions, of particular interest from a hepatoxicology standpoint is the oxidative
defluorination reaction. This reaction involves the removal of the fluorine group attached to the
benzene ring and its replacement with a hydroxyl (-OH) group. In this research project, the
oxidative defluorination reaction is catalyzed by a family of enzymes called cytochrome P450s.
Initial data collected on the reaction of 5F2O with two different cytochrome P450 enzymes
(P4501A1 and P4502A6) indicate that 5F2O is modified to form an intermediate product which is
hypothesized to be a reactive quinoneamine similar to the quinoneamine metabolite indicated in
Tylenol toxicity.
This research project has confirmed that the reaction between 5F2O and purified human
P4502A6 enzyme is producing the expected oxidative defluorination reaction product 5hydroxyoxindole via high-performance liquid chromatography (HPLC). Due to its high
reactivity, the proposed quinoneamine intermediate is not able to be observed directly. However,

reactions performed using a trapping agent called glutathione showed the formation of a unique
stable product that was observed via HPLC. Evidence suggests that this stable product is an
adduct of the proposed quinoneamine intermediate. Future research work will include additional
analysis of this stable product in hopes of confirming its identity as well as testing whether
treatment with various chemical agents are able to mediate or prevent the formation of the
proposed reactive quinoeamine intermediate (and thereby prevent formation of the glutathionedependent stable product previously observed).

Christian worldview integration:
Inherent to a faithful Christian worldview is a theology of illness and suffering. The
historical account of Genesis indicates that God’s initial creation was “very good,” meaning that
it was without flaw and perfect, like God Himself (Genesis 1:31). However, the sin of humans in
Genesis 3 marked a transition from a perfect creation to an imperfect world as a result of Adam
and Eve’s sin against God. The world we now know, which is capable of causing illness and
suffering, is a direct result of sin. 1 Corinthians 15:21-22 states that death (both physical and
spiritual) is a direct result of Adam’s sinfulness, and provides the basis for Christian theology of
illness. In this view, illnesses such as cancer are a direct result of sinfulness and are evidence of
humanity’s need for Christ.
However, the example of Christ reveals the importance of showing compassion to those
who are experiencing physical suffering. Throughout the gospels, Jesus takes action to relieve
the suffering of those with physical infirmities– healing the blind, lame, and leprous (Matthew
14:13-14, Matthew 20:30-34, among many others). Thus as Christians, it is extremely important
to seek to help those who are experiencing physical suffering. Medication is a key element of
care for those afflicted with various illnesses, with chemotherapy drugs representing a significant

component of care for those afflicted by cancer. In seeking to compassionately provide care, it is
important to ensure that medications given to those who are ill do not worsen their condition or
cause other negative side effects. This research project explores potential liver toxicity as a result
of administration of 5-fluorooxindole containing-medications (such as the anti-cancer drug
Famitinib). The results of this project will help to inform further research and development of
anti-cancer drugs, and help to ensure that patients are not unwittingly injured by medications
administered to them. To perform research of this kind is to show the compassion exemplified by
Jesus by seeking to protect and bring healing to those who are ill.

